vimarsana.com
Home
Live Updates
New Comprehensive Phase 3 Data Show First-in-Class TREMFYA® (guselkumab) Provided Durable Improvements in Measures of Psoriatic Arthritis (PsA) Disease Activity Through Two Years : vimarsana.com
New Comprehensive Phase 3 Data Show First-in-Class TREMFYA® (guselkumab) Provided Durable Improvements in Measures of Psoriatic Arthritis (PsA) Disease Activity Through Two Years
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced comprehensive efficacy and safety data from the DISCOVER–2 trial of...
Related Keywords
Langley
,
British Columbia
,
Canada
,
Japan
,
Spring House
,
United States
,
Horsham
,
Saskatchewan
,
American
,
Jennifer Mcintyre
,
Alyssa Johnsen
,
Donvitot Creakyjoints
,
Philip Mease
,
Bridget Kimmel
,
Zismand Comorbidities
,
Item Short Form Survey Physical Component Summary
,
American College Of Rheumatology
,
Janssen Research Development
,
Janssen Pharmaceutical Companies
,
Janssen Pharmaceutical Companies Of Johnson
,
University Of Washington School Medicine
,
National Psoriasis Foundation
,
Swedish Medical Center Providence St
,
Journal Of The American Academy Dermatology
,
None Of The Janssen Pharmaceutical Companies
,
Stanford Health Assessment Questionnaire
,
Joseph Health
,
Drug Administration
,
Health Assessment Questionnaire Disability Index
,
Arthritis Research Therapy
,
Exchange Commission
,
Companies Of Johnson
,
Group For Research
,
Rheumatology Research
,
Johnson
,
American College
,
Global Assessment
,
Swedish Medical
,
Clinical Professor
,
Washington School
,
Heijde Modified Sharp
,
Vice President
,
Rheumatology Disease Area Leader
,
Janssen Research
,
Psoriasis Area
,
Severity Index
,
Psoriatic Arthritis
,
Mental Component Score
,
Prescribing Information
,
Medication Guidefor
,
Pharmaceutical Companies
,
Infectious Diseases
,
Private Securities Litigation Reform Act
,
Annual Report
,
Note Regarding Forward Looking
,
Quarterly Report
,
Monoclonal Antibody Specific
,
Placebo Controlled Study Conducted
,
Active Psoriatic
,
Specific Monoclonal Antibody
,
Through One Year
,
Naive Patients With Psoriatic
,
Safety Results Through One Year
,
American Academy
,
Safety Results Of Two
,
Participants With Active Psoriatic Arthritis
,
Accessed October
,
Gone Prior
,
Guselkumab Administered Subcutaneously
,
Dermatological Treatment
,
Accessed Oct
,
Rheum Dis
,
Painful Arthritis Symptom You Should Know
,
Sausage Finger Swelling You Should Know
,
Rambam Maimonides Med
,
About Psoriatic
,
Immune Based Therapies
,
Study Evaluating
,
Janssen Pharmaceutical Companies Of Johnson Amp
,
Health Care Amp Hospitals
,
Medical Pharmaceuticals
,
Pharmaceuticals
,
Clinical Trials Amp Medical Discoveries
,
vimarsana.com © 2020. All Rights Reserved.